Z-0752-2021 Class II Terminated

Recalled by Roche Diagnostics Operations, Inc. — Indianapolis, IN

FDA device recall Z-0752-2021 was initiated by Roche Diagnostics Operations, Inc. on November 23, 2020 and is designated Class II. Reason for recall: During the subsequent pipetting (1st or 2nd measurement), the residual reagent can sporadically be transferred from the conus into the reaction cuvette and lead to inaccurately low results for the af… The recall status is terminated (terminated July 6, 2023). Affected quantity: 152 kits and 7 units.

Recall Details

Product Type
Devices
Report Date
January 6, 2021
Initiation Date
November 23, 2020
Termination Date
July 6, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
152 kits and 7 units

Product Description

cobas pro integrated solutions -cobas c 503, Analyzer, chemistry (photometric discrete), for clinical use

Reason for Recall

During the subsequent pipetting (1st or 2nd measurement), the residual reagent can sporadically be transferred from the conus into the reaction cuvette and lead to inaccurately low results for the affected TDMs (Therapeutic Drug Monitoring).

Distribution Pattern

Domestic: IL, FL, GA, WV

Code Information

Catalog Number 08445605190 08445567190 08253153190 08058580190